Generalized fixed drug eruption following Pfizer‐BioNtech COVID‐19 vaccination. Issue 12 (8th December 2022)

• Record Type: Journal Article
• Authors: Kabir, Soodeh; Feit, Eric J.; Heilman, Edward R.
• Is Part Of: Clinical case reports. Volume 10:Issue 12(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-12-08
• Subjects: drug rash -- Exanthem -- fixed drug eruption, COVID‐19 vaccine -- hyperpigmentation -- mRNA vaccine -- skin; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.6684
• Languages: English
• ISSNs: 2050-0904

Abstract

Abstract: Fixed drug eruption is a cutaneous drug reaction which recurs at the same site when the individual is exposed to the causative drug, characterized by single or multiple round sharply demarcated erythematous‐to‐violaceous patches. Here, we report a patient with generalized non‐bullous fixed drug eruption following mRNA‐based Pfizer‐BioNTech COVID‐19 vaccine. Abstract : Fixed drug eruption following COVID‐19 vaccination has been reported on rare occasions which includes bullous and non‐bullous lesions. The presented case adds to this list a "multiple non‐bullous" presentation of FDE following mRNA COVID‐19 vaccine.